Literature DB >> 10644378

Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.

E T Sawai1, M S Hamza, M Ye, K E Shaw, P A Luciw.   

Abstract

Rhesus macaques infected with simian immunodeficiency virus (SIV) containing either a large nef deletion (SIVmac239Delta(152)nef) or interleukin-2 in place of nef developed high virus loads and progressed to simian AIDS. Viruses recovered from both juvenile and neonatal macaques with disease produced a novel truncated Nef protein, tNef. Viruses recovered from juvenile macaques infected with serially passaged virus expressing tNef exhibited a pathogenic phenotype. These findings demonstrated strong selective pressure to restore expression of a truncated Nef protein, and this reversion was linked to increased pathogenic potential in live attenuated SIV vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644378      PMCID: PMC111683          DOI: 10.1128/jvi.74.4.2038-2045.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

Review 2.  SIV/HIV recombinants and their use in studying biological properties.

Authors:  R Shibata; A Adachi
Journal:  AIDS Res Hum Retroviruses       Date:  1992-03       Impact factor: 2.205

3.  Binding of c-Raf1 kinase to a conserved acidic sequence within the carboxyl-terminal region of the HIV-1 Nef protein.

Authors:  D R Hodge; K J Dunn; G K Pei; M K Chakrabarty; G Heidecker; J A Lautenberger; K P Samuel
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

4.  Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2.

Authors:  B R Gundlach; H Linhart; U Dittmer; S Sopper; S Reiprich; D Fuchs; B Fleckenstein; G Hunsmann; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques.

Authors:  I H Khan; E T Sawai; E Antonio; C J Weber; C P Mandell; P Montbriand; P A Luciw
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4.

Authors:  X Lu; H Yu; S H Liu; F M Brodsky; B M Peterlin
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

8.  Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.

Authors:  T W Baba; Y S Jeong; D Pennick; R Bronson; M F Greene; R M Ruprecht
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

9.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

Authors:  M D Daniel; F Kirchhoff; S C Czajak; P K Sehgal; R C Desrosiers
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

10.  Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.

Authors:  M L Marthas; R A Ramos; B L Lohman; K K Van Rompay; R E Unger; C J Miller; B Banapour; N C Pedersen; P A Luciw
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more
  36 in total

1.  Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.

Authors:  Barbara L Shacklett; Karen E S Shaw; Lou A Adamson; David T Wilkens; Catherine A Cox; David C Montefiori; Murray B Gardner; Pierre Sonigo; Paul A Luciw
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  A human immunodeficiency virus type 1-infected individual with low viral load harbors a virus variant that exhibits an in vitro RNA dimerization defect.

Authors:  Hendrik Huthoff; Atze T Das; Monique Vink; Bep Klaver; Fokla Zorgdrager; Marion Cornelissen; Ben Berkhout
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source.

Authors:  Melissa J Churchill; David I Rhodes; Jennifer C Learmont; John S Sullivan; Steven L Wesselingh; Ian R C Cooke; Nicholas J Deacon; Paul R Gorry
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

5.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

6.  T-cell receptor:CD3 down-regulation is a selected in vivo function of simian immunodeficiency virus Nef but is not sufficient for effective viral replication in rhesus macaques.

Authors:  Jan Münch; Ajit Janardhan; Nicole Stolte; Christiane Stahl-Hennig; Peter Ten Haaft; Jonathan L Heeney; Tomek Swigut; Frank Kirchhoff; Jacek Skowronski
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 7.  Using death to one's advantage: HIV modulation of apoptosis.

Authors:  T M Ross
Journal:  Leukemia       Date:  2001-03       Impact factor: 11.528

8.  Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.

Authors:  Soumi Gupta; Christian M Leutenegger; Gregg A Dean; Jonathan D Steckbeck; Kelly Stefano Cole; Ellen E Sparger
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression.

Authors:  Nicoletta Casartelli; Gigliola Di Matteo; Marina Potestà; Paolo Rossi; Margherita Doria
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.

Authors:  Zahida Ali; Lin Yan; Nicholas Plagman; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Francois Villinger; Zheng W Chen
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.